Potentially preventable hospitalizations and use of preventive services among people with multiple sclerosis: Large cohort study, USA.

Ambulatory care sensitive conditions Multiple Sclerosis Preventable hospitalization Preventive medicine

Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 10 05 2022
revised: 15 07 2022
accepted: 10 08 2022
pubmed: 29 8 2022
medline: 15 12 2022
entrez: 28 8 2022
Statut: ppublish

Résumé

Individuals with multiple sclerosis (MS) report barriers to accessing care, including receipt of preventive services. Potentially preventable hospitalization (PPH) is an important marker for access to, and receipt of timely care. However, few national studies have examined PPH risk in people with MS or considered the role of preventive care in reducing PPH risk among this patient population. Our objective was to examine PPH risk among adults with MS compared with their counterparts without MS. Optum® Clinformatics® Data Mart (2007-2017) was used to identify 6198 individuals with an MS diagnosis and their propensity-score matched counterparts without MS. Diagnostic and procedural codes were used to identify the presence of preventive hospitalizations, which were defined as quality indicators by the Agency for Healthcare Research and Quality (AHRQ) during the 4-year follow-up period since the diagnosis of MS. Information on receipt of preventive services and office visits was also extracted. Adjusted generalized estimating equations were used to examine the association between MS diagnosis and PPHs. To examine the role of preventive services on odds of PPH amongst people with MS, we reported the adjusted marginal odds ratio (OR) and 95% confidence intervals (CI). The rate of any PPH among people with MS was double that of those without MS (131.6 vs 62.5 per 10,000). We identified higher odds of specific PPH indicators among people with MS compared to those without. Individuals with MS had 65% higher odds of hospitalization for pneumonia (OR=1.65, 95% CI: 1.01, 2.30), with similar significant findings observed for urinary tract infections (OR=4.90, 95% CI: 2.51, 9.57). In MS patients, receipt of preventive services, namely cholesterol screening (OR=0.76, 95% CI: 0.60, 0.95) and annual wellness visits were associated with lower odds of any PPH (OR=0.57, 95% CI: 0.43, 0.76). People with MS were at a higher risk for PPHs compared with their counterparts without MS. Use of appropriate preventive services reduced the risk of PPH among the general population and among those with MS. More efforts are needed to encourage and facilitate the use of preventive care among people with MS. Receipt of timely and appropriate preventive care in this population may reduce the risk for PPH.

Sections du résumé

BACKGROUND BACKGROUND
Individuals with multiple sclerosis (MS) report barriers to accessing care, including receipt of preventive services. Potentially preventable hospitalization (PPH) is an important marker for access to, and receipt of timely care. However, few national studies have examined PPH risk in people with MS or considered the role of preventive care in reducing PPH risk among this patient population. Our objective was to examine PPH risk among adults with MS compared with their counterparts without MS.
METHODS METHODS
Optum® Clinformatics® Data Mart (2007-2017) was used to identify 6198 individuals with an MS diagnosis and their propensity-score matched counterparts without MS. Diagnostic and procedural codes were used to identify the presence of preventive hospitalizations, which were defined as quality indicators by the Agency for Healthcare Research and Quality (AHRQ) during the 4-year follow-up period since the diagnosis of MS. Information on receipt of preventive services and office visits was also extracted. Adjusted generalized estimating equations were used to examine the association between MS diagnosis and PPHs. To examine the role of preventive services on odds of PPH amongst people with MS, we reported the adjusted marginal odds ratio (OR) and 95% confidence intervals (CI).
RESULTS RESULTS
The rate of any PPH among people with MS was double that of those without MS (131.6 vs 62.5 per 10,000). We identified higher odds of specific PPH indicators among people with MS compared to those without. Individuals with MS had 65% higher odds of hospitalization for pneumonia (OR=1.65, 95% CI: 1.01, 2.30), with similar significant findings observed for urinary tract infections (OR=4.90, 95% CI: 2.51, 9.57). In MS patients, receipt of preventive services, namely cholesterol screening (OR=0.76, 95% CI: 0.60, 0.95) and annual wellness visits were associated with lower odds of any PPH (OR=0.57, 95% CI: 0.43, 0.76).
CONCLUSION CONCLUSIONS
People with MS were at a higher risk for PPHs compared with their counterparts without MS. Use of appropriate preventive services reduced the risk of PPH among the general population and among those with MS. More efforts are needed to encourage and facilitate the use of preventive care among people with MS. Receipt of timely and appropriate preventive care in this population may reduce the risk for PPH.

Identifiants

pubmed: 36031692
pii: S2211-0348(22)00612-5
doi: 10.1016/j.msard.2022.104105
pmc: PMC10424261
mid: NIHMS1920360
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104105

Subventions

Organisme : ACL HHS
ID : 90RTHF0001
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There is no conflict of interest to report.

Références

Arch Phys Med Rehabil. 2022 Jul;103(7):1255-1262
pubmed: 35691712
Mult Scler Relat Disord. 2020 Nov;46:102462
pubmed: 32890816
Mult Scler Relat Disord. 2020 Oct;45:102420
pubmed: 32736217
Disabil Health J. 2015 Jan;8(1):29-34
pubmed: 25130596
Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1046-57
pubmed: 23917100
Health Serv Res. 2002 Dec;37(6):1509-29
pubmed: 12546284
Eur J Neurol. 2013 Aug;20(8):1153-60
pubmed: 23496086
Psychol Psychother. 2009 Mar;82(Pt 1):41-56
pubmed: 18727845
Mult Scler Relat Disord. 2021 Jun;51:102884
pubmed: 33799287
Neurology. 2009 Jan 13;72(2):117-24
pubmed: 18971448
Mult Scler. 2009 Mar;15(3):385-92
pubmed: 19153176
Am J Clin Exp Immunol. 2014 Feb 27;3(1):57-67
pubmed: 24660122
Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 23;6(1):55-68
pubmed: 35005438
Bone. 2021 Jan;142:115700
pubmed: 33091639
Mult Scler. 2007 May;13(4):547-58
pubmed: 17463077
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Respir Med. 2015 Jun;109(6):671-9
pubmed: 25724874
Neurology. 2014 Sep 2;83(10):929-37
pubmed: 25085638
Int J MS Care. 2015 Sep-Oct;17(5):221-30
pubmed: 26472943
Neurology. 2019 Mar 5;92(10):e1029-e1040
pubmed: 30770430
Am J Manag Care. 2012 Dec 01;18(12):e453-60
pubmed: 23286675
Int J MS Care. 2020 Mar-Apr;22(2):91-99
pubmed: 32410904
Mult Scler Relat Disord. 2019 Feb;28:305-308
pubmed: 30641355
J Womens Health Gend Based Med. 2000 May;9(4):389-95
pubmed: 10868611
Healthcare (Basel). 2017 Sep 12;5(3):
pubmed: 28895898
Mult Scler Int. 2013;2013:436929
pubmed: 23766908
Mult Scler Relat Disord. 2022 Jan;57:103351
pubmed: 35158460
Int J MS Care. 2015 Jul-Aug;17(4):200-5
pubmed: 26300706

Auteurs

Anam Khan (A)

School of Public Health, University of Michigan, Ann Arbor, MI, USA; Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.

Paul Lin (P)

Institute for Healthcare Policy and Innovation, Michigan Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd., Building 14, Room G234, Ann Arbor, MI 48109, USA.

Neil Kamdar (N)

Institute for Healthcare Policy and Innovation, Michigan Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd., Building 14, Room G234, Ann Arbor, MI 48109, USA; Department of Obstetrics and Gynecology, Michigan Medicine, University of Michigan, USA; Department of Emergency Medicine, Michigan Medicine, University of Michigan, USA; Department of Surgery, Michigan Medicine, University of Michigan, USA; Department of Neurosurgery, Michigan Medicine, University of Michigan, USA.

Mark Peterson (M)

Institute for Healthcare Policy and Innovation, Michigan Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd., Building 14, Room G234, Ann Arbor, MI 48109, USA; Department of Physical Medicine and Rehabilitation, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.

Elham Mahmoudi (E)

Institute for Healthcare Policy and Innovation, Michigan Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd., Building 14, Room G234, Ann Arbor, MI 48109, USA; Department of Family Medicine, Michigan Medicine, University of Michigan, USA. Electronic address: Mahmoudi@med.umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH